glp-1 after tummy tuck Medications Drive Surge in Tucks and Body Contouring Surgeries Amid Weight Loss Trends Excess Skin Removal Following Bariatric

GLP-1 (glucagon-like peptide-1) is a hormone that plays a crucial role in regulating blood sugar levels and appetite

Somewhat paradoxically, a final nonsurgical treatment that we believe should be considered in some patients is targeted lipolysis, for example using deoxycholic acid or cryolipolysis

The STEP trials for semaglutide 2.4 mg (Wegovy) showed: Average weight loss of approximately 15% of body weight over 68 weeks One-third of participants lost 20% or more of body weight Significant reductions in waist circumference, blood pressure, and cardiovascular risk markers The SURMOUNT trials for tirzepatide (Zepbound) showed even more impressive results: Average weight loss of 20-25% at the highest dose (15 mg) over 72 weeks More than half of participants lost 20% or more of body weight Significant improvements in type 2 diabetes markers, blood pressure, and lipid profiles The head-to-head comparison is clear

Diabetes Metab Res Rev 2025;41:e70037.PubMedPMC 81

For a broader perspective on affordable compounded GLP-1 options , comparing multiple providers and pharmacies can help you find the best value for your situation